ObjectiveThis study compared the primary stability of two commercially
available acetabular components from the same manufacturer, which
differ only in geometry; a hemispherical and a peripherally enhanced
design (peripheral self-locking (PSL)). The objective was to determine
whether altered geometry resulted in better primary stability.MethodsAcetabular components were seated with 0.8 mm to 2 mm interference
fits in reamed polyethylene bone substrate of two different densities
(0.22 g/cm3 and 0.45 g/cm3). The primary stability
of each component design was investigated by measuring the peak
failure load during uniaxial pull-out and tangential lever-out tests.ResultsThere was no statistically significant difference in seating
force (p = 0.104) or primary stability (pull-out p = 0.171, lever-out
p = 0.087) of the two components in the low-density substrate. Similarly,
in the high-density substrate, there was no statistically significant
difference in the peak pull-out force (p = 0.154) or lever-out moment
(p = 0.574) between the designs. However, the PSL component required
a significantly higher seating force than the hemispherical cup
in the high-density bone analogue (p = 0.006).ConclusionsHigher seating forces associated with the PSL design may result
in inadequate seating and increased risk of component malpositioning
or acetabular fracture in the intra-operative setting in high-density
bone stock. Our results, if translated clinically, suggest that
a purely hemispherical geometry may have an advantage over a peripherally
enhanced geometry in high density bone stock.Cite this article: Bone Joint Res 2013;2:264–9.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.